PFO-spectrum disorder: two different cerebrovascular diseases in patients with PFO as detected by AI brain imaging software.

cerebral white matter lesions contrast transcranial Doppler magnetic resonance imaging patent foramen ovale stroke transesophageal echocardiography

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2024
Historique:
received: 17 12 2023
accepted: 06 02 2024
medline: 5 3 2024
pubmed: 5 3 2024
entrez: 5 3 2024
Statut: epublish

Résumé

Patent foramen ovale (PFO) is a prevalent cardiac remnant of fetal anatomy that may pose a risk factor for stroke in some patients, while others can present with asymptomatic white matter (WM) lesions. The current study aimed to test the hypothesis that patients with a PFO who have a history of stroke or transient ischemic attack, compared to those without such a history, have a different burden and distribution of cerebral WM hyperintensities. Additionally, we tested the association between PFO morphological characteristics and severity of shunt, and their impact on the occurrence of ischemic cerebral vascular events and on the burden of cerebral WM lesions. Retrospective, case-control study that included patients with PFO confirmed by transesophageal echocardiography. Right-to-left shunt size was assessed using transcranial Doppler ultrasound. Cerebral MRIs were analyzed for all participants using the semi-automated Quantib NDTM software for the objective quantification of WM lesions. WM lesions volume was compared between patients with and without a history of stroke. Additionally, the anatomical characteristics of PFOs were assessed to explore their relation to stroke occurrence and WM lesions volume. Of the initial 264 patients diagnosed with PFO, 67 met the inclusion criteria and were included in the analysis. Of them, 62% had a history of PFO-related stroke/TIA. Overall burden of WM lesions, including stroke volume, was not significantly different ( We suggest that PFO may be associated with the development of two distinct cerebrovascular conditions (stroke and "silent" WM lesions), each characterized by unique imaging patterns. Further studies are needed to identify better the "at-risk" PFOs and gain deeper insights into their clinical implications.

Sections du résumé

Background UNASSIGNED
Patent foramen ovale (PFO) is a prevalent cardiac remnant of fetal anatomy that may pose a risk factor for stroke in some patients, while others can present with asymptomatic white matter (WM) lesions. The current study aimed to test the hypothesis that patients with a PFO who have a history of stroke or transient ischemic attack, compared to those without such a history, have a different burden and distribution of cerebral WM hyperintensities. Additionally, we tested the association between PFO morphological characteristics and severity of shunt, and their impact on the occurrence of ischemic cerebral vascular events and on the burden of cerebral WM lesions.
Patients and methods UNASSIGNED
Retrospective, case-control study that included patients with PFO confirmed by transesophageal echocardiography. Right-to-left shunt size was assessed using transcranial Doppler ultrasound. Cerebral MRIs were analyzed for all participants using the semi-automated Quantib NDTM software for the objective quantification of WM lesions. WM lesions volume was compared between patients with and without a history of stroke. Additionally, the anatomical characteristics of PFOs were assessed to explore their relation to stroke occurrence and WM lesions volume.
Results UNASSIGNED
Of the initial 264 patients diagnosed with PFO, 67 met the inclusion criteria and were included in the analysis. Of them, 62% had a history of PFO-related stroke/TIA. Overall burden of WM lesions, including stroke volume, was not significantly different (
Discussion UNASSIGNED
We suggest that PFO may be associated with the development of two distinct cerebrovascular conditions (stroke and "silent" WM lesions), each characterized by unique imaging patterns. Further studies are needed to identify better the "at-risk" PFOs and gain deeper insights into their clinical implications.

Identifiants

pubmed: 38440117
doi: 10.3389/fneur.2024.1357348
pmc: PMC10909929
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1357348

Informations de copyright

Copyright © 2024 Badea, Mihăilă-Bâldea, Ribigan, Negrilă, Grecu, Marinescu, Antochi, Tiu, Vinereanu and Popescu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Raluca Ștefania Badea (RȘ)

Department of Neurology, University and Emergency Hospital, Bucharest, Romania.
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Sorina Mihăilă-Bâldea (S)

University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Department of Cardiology and Cardiovascular Surgery, University and Emergency Hospital, Bucharest, Romania.

Athena Ribigan (A)

Department of Neurology, University and Emergency Hospital, Bucharest, Romania.
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Anca Negrilă (A)

Department of Neurology, University and Emergency Hospital, Bucharest, Romania.

Nicolae Grecu (N)

Department of Neurology, University and Emergency Hospital, Bucharest, Romania.
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Andreea Nicoleta Marinescu (AN)

Department of Radiology, University and Emergency Hospital, Bucharest, Romania.

Florina Antochi (F)

Department of Neurology, University and Emergency Hospital, Bucharest, Romania.

Cristina Tiu (C)

Department of Neurology, University and Emergency Hospital, Bucharest, Romania.
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Dragos Vinereanu (D)

University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Department of Cardiology and Cardiovascular Surgery, University and Emergency Hospital, Bucharest, Romania.

Bogdan Ovidiu Popescu (BO)

University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Department of Neurology, Colentina Clinical Hospital, Bucharest, Romania.

Classifications MeSH